Get the SPI Wire

FedEx Corporation

NYSE:FDX
Annual Meeting

of Shareholders

MEETING DATE

09/28/2026
DEF 14A FILED
08/17/2026
PUBLISHED
08/17/2026 8:04 pm
TIME TO PUBLISH
08/19/2026
METHODOLOGY
approve
EXCHANGE NYSE:FDX· CUSIP 31428X106 · CLASS common stock · CIK 0001048911

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

3
FOR
3
AGAINST
0
WITHHOLD
6
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Election of Directors
board
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states the election is uncontested and the Board recommends each of the eleven nominees.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Advisory Vote to Approve Named Executive Officer Compensation
compensation
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

The filing states 2025 say-on-pay support was 63% and opposition centered on a former executive's separation package.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Ratification of the Appointment of the Independent Registered Public Accounting Firm
auditor
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The Audit and Finance Committee appointed Ernst & Young and states it has policies to ensure independence.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
Independent Board Chair
shareholder_proposal
Elevated
Against
Board AGAINST · Duopoly unknown — No divergence flagged

The filing states the Board reviews leadership structure annually and maintains a Lead Independent Director.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
Lower threshold to call a special meeting
shareholder_proposal
Elevated
Against
Board AGAINST · Duopoly unknown — No divergence flagged

The filing states stockholders already may call a special meeting if they own 20% of common stock.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
6
Report on Risks Related to Distributing Abortion Drugs
shareholder_proposal
Elevated
For
Board AGAINST · Duopoly unknown — ⚠ Divergence flagged

The proposal cites a Louisiana lawsuit challenging FDA rules and state laws restricting abortion drugs.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

1428d1b29b9c8e0d94fcdfd14de82ff96f12b13fcfbec01375868d38210d47c8

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates